Vanton Research Laboratory, LLC is a privately owned contract research organization (CRO) specializing in development of non-conventional drug delivery systems. It also provides a comprehensive range of fully integrated Pharmaceutical Development Services including pre-formulation, formulation, analytical development, and clinical manufacturing. In addition to CRO services, Vanton also develops in-house specialty products. The company’s pipeline products include a subcutaneous depot system using its proprietary molecular caging (MC) technology to deliver Ropivacaine for managing post-operational pain, in addition to a range of chronic disease treatment products using its novel sustained released oral disintegrating tablet (ODT-SR) technology.